KILITCH vs PGHL: Stock Comparison

KILITCH vs PROCTER & GAMBLE HEALTH LUpdated 2 Jul 26, 4:08 PM ISTNSE & company filings

PROCTER & GAMBLE HEALTH L is the larger company by market capitalisation. KILITCH shows a lower P/E and faster revenue growth, while PROCTER & GAMBLE HEALTH L shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

KILITCH leads 5; PGHL leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

KILITCHPGHL

Valuation lens

What price are you paying?

Market CapContext only
₹630 Cr
₹9,379 Cr
P/E RatioKILITCH has the lower reading
20.22x
26.43x
P/B RatioKILITCH has the lower reading
2.17x
17.98x
EPSPGHL has the higher reading
₹1.45
₹57.92
Book ValueContext only
₹79.19
₹316.01
Dividend YieldPGHL has the higher reading
0%
3.45%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
PGHL is the larger company
₹9,379 Cr vs ₹630 Cr
P/E Ratio
KILITCH has a lower P/E
20.22x vs 26.43x
P/B Ratio
KILITCH has a lower P/B
2.17x vs 17.98x
EPS
PGHL has higher earnings per share
₹57.92 vs ₹1.45
Dividend Yield
PGHL has a higher dividend yield
3.45% vs 0%
Revenue Growth (TTM YoY)
KILITCH has faster revenue growth
46.3% vs 19.1%
EPS Growth (TTM YoY)
PGHL has faster EPS growth
54.6% vs 26.5%
Qtr Sales Growth
KILITCH has stronger quarterly sales growth
-8.84% vs -74.17%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKILITCHPGHL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricKILITCHPGHL
Live Price₹196.99₹5,660
Day Change-4.15%-1.69%
Volume1.36 L7,255
52-Week High₹439₹6,975
52-Week Low₹117.25₹4,707
Distance from 52W High-55.13%-18.85%

Valuation

MetricKILITCHPGHL
Market Cap₹630 Cr₹9,379 Cr
P/E Ratio20.22x26.43x
P/B Ratio2.17x17.98x
EPS₹1.45₹57.92
Book Value₹79.19₹316.01
Dividend Yield0%3.45%

Growth

MetricKILITCHPGHL
Revenue Growth (TTM YoY)46.3%19.1%
EPS Growth (TTM YoY)26.5%54.6%
Qtr Sales Growth-8.84%-74.17%
Qtr Profit Growth156.81%-70.59%

Profitability & Leverage

MetricKILITCHPGHL
ROE9.73%62.32%
ROCE8.32%92.1%
Net Margin12.81%23.22%
Operating Margin23.33%31.99%
Debt to Equity0.27x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKILITCHPGHL
Promoter Holding63.77%0%
FII Holding0.12% 0.12 pp6.33% 0.13 pp
DII Holding0%12.44% 1.23 pp
Public Holding36.11% 0.11 pp29.42% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KILITCH and PROCTER & GAMBLE HEALTH L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.